Results 51 to 60 of about 7,177,989 (337)

Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

open access: yesJAMA Surgery, 2021
Key Points Question Is there any difference in the safety of neoadjuvant chemoradiotherapy (nCRT) followed by minimally invasive esophagectomy (MIE) for locally advanced esophageal squamous cell carcinoma (ESCC) compared with that of neoadjuvant ...
Hao Wang   +26 more
semanticscholar   +1 more source

Application of Pathological Staging in Esophageal Squamous Cell Carcinoma

open access: yes, 2020
Pathological staging is the most important factor that determines the prognosis and management of patients with esophageal squamous cell carcinoma. The method for the pathological staging in esophageal squamous cell carcinoma involves assessment of ...
Lam, AK, Alfred K. Lam
core   +1 more source

MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells [PDF]

open access: yes, 2011
Background: Esophageal squamous cell carcinoma (ESCC) is often diagnosed at later stages until they are incurable. MicroRNA (miR) is a small, non-coding RNA that negatively regulates gene expression mainly via translational repression.
Yamashita, S.   +62 more
core   +1 more source

Radiotherapy for Thoracic Esophageal Squamous Cell Carcinoma

open access: yes, 2020
Esophageal squamous cell carcinoma (ESCC) is an aggressive disease. Many patients have locally advanced disease or already have distant metastasis at presentation.
Lam, KO, Chan, WLW, Kwong, DLW
core   +1 more source

promoter methylation is associated with prognosis in esophageal squamous cell carcinoma

open access: yesTumor Biology, 2017
Esophageal squamous cell carcinoma is a commonly malignant tumor of digestive tract with poor prognosis. Previous studies suggested that forkhead box F2 ( FOXF2 ) could be a candidate gene for assessing and predicting the prognosis of human cancers ...
Xiaoying Chen   +10 more
doaj   +1 more source

Esophageal Neuroendocrine Carcinoma With Focal Squamous Cell Carcinoma Component

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2020
This study was about a 70-year-old man with progressive dysphagia. Esophagogastroduodenoscopy showed a 1.2-cm circumferential ulcerative mass at the level of 23 cm from the upper incisors in the upper esophagus.
Min Kyun Kang, Do Kyun Kang
doaj   +1 more source

Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment

open access: yesNature Communications, 2020
Cancer immunotherapy has revolutionized cancer treatment, and it relies heavily on the comprehensive understanding of the immune landscape of the tumor microenvironment (TME).
Ying-Xia Zheng   +18 more
semanticscholar   +1 more source

Identifying a confused cell identity for esophageal squamous cell carcinoma

open access: yesSignal Transduction and Targeted Therapy, 2022
The cell identity of malignant cells and how they acquire it are fundamental for our understanding of cancer. Here, we report that esophageal squamous cell carcinoma (ESCC) cells display molecular features equally similar but distinct to all three types ...
Xiangyu Pan   +18 more
semanticscholar   +1 more source

Introduction: Esophageal Squamous Cell Carcinoma—Current Status and Future Advances

open access: yes, 2020
Esophageal squamous cell carcinoma is the most common histological subtype of esophageal cancer. The carcinoma is more common in high-incidence areas such as in Central and Southeast Asia, Eastern and Southern Africa, South America, etc.
Lam, AK, Alfred K. Lam
core   +1 more source

Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double‐blind randomized phase 2 trial

open access: yesCancer Medicine, 2021
Currently, there are no randomized trials on the effect of antiangiogenic therapy in patients with esophageal squamous cell carcinoma (ESCC). The following study investigated the efficacy and safety of anlotinib in patients with advanced ESCC who were ...
Jing Huang   +15 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy